Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12.

Staes C, Jacobs J, Mayer J, Allen J.

Am J Health Syst Pharm. 2013 Aug 1;70(15):1301-12. doi: 10.2146/ajhp130049. Review.

2.

How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak.

Teshome BF, Reveles KR, Lee GC, Ryan L, Frei CR.

J Am Pharm Assoc (2003). 2014 Jul-Aug;54(4):441-5. doi: 10.1331/JAPhA.2014.14011.

PMID:
25063265
3.

Sterile compounding: clinical, legal, and regulatory implications for patient safety.

Qureshi N, Wesolowicz L, Stievater T, Lin AT.

J Manag Care Spec Pharm. 2014 Dec;20(12):1183-91. Review.

4.

A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy.

Sunenshine RH, Tan ET, Terashita DM, Jensen BJ, Kacica MA, Sickbert-Bennett EE, Noble-Wang JA, Palmieri MJ, Bopp DJ, Jernigan DB, Kazakova S, Bresnitz EA, Tan CG, McDonald LC.

Clin Infect Dis. 2007 Sep 1;45(5):527-33.

5.

Potential risks of pharmacy compounding.

Gudeman J, Jozwiakowski M, Chollet J, Randell M.

Drugs R D. 2013 Mar;13(1):1-8. doi: 10.1007/s40268-013-0005-9. Review.

6.
7.

Causes and root causes of a multistate fungal meningitis outbreak.

Lipowski EE, Smith WT, Navarro RP.

J Am Pharm Assoc (2003). 2015 Mar-Apr;55(2):118. doi: 10.1331/JAPhA.2015.14220. No abstract available.

PMID:
25616150
8.

CDC probes new outbreak associated with compounded steroids.

Kuehn BM.

JAMA. 2013 Jun 26;309(24):2541. doi: 10.1001/jama.2013.7701. No abstract available.

PMID:
23800915
9.
10.

Outbreak of Serratia marcescens infections following injection of betamethasone compounded at a community pharmacy.

Civen R, Vugia DJ, Alexander R, Brunner W, Taylor S, Parris N, Wasserman R, Abbott S, Werner SB, Rosenberg J.

Clin Infect Dis. 2006 Oct 1;43(7):831-7.

11.

Fungal infections associated with contaminated methylprednisolone in Tennessee.

Kainer MA, Reagan DR, Nguyen DB, Wiese AD, Wise ME, Ward J, Park BJ, Kanago ML, Baumblatt J, Schaefer MK, Berger BE, Marder EP, Min JY, Dunn JR, Smith RM, Dreyzehner J, Jones TF; Tennessee Fungal Meningitis Investigation Team..

N Engl J Med. 2012 Dec 6;367(23):2194-203. doi: 10.1056/NEJMoa1212972.

12.

Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.

Kastango ES.

JPEN J Parenter Enteral Nutr. 2012 Mar;36(2 Suppl):38S-39S. doi: 10.1177/0148607111434779.

PMID:
22275322
13.

Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm.

Guharoy R, Noviasky J, Haydar Z, Fakih MG, Hartman C.

Chest. 2013 Apr;143(4):896-900. doi: 10.1378/chest.13-0212.

PMID:
23412546
14.

Outbreak of bacteremia due to Burkholderia contaminans linked to intravenous fentanyl from an institutional compounding pharmacy.

Moehring RW, Lewis SS, Isaacs PJ, Schell WA, Thomann WR, Althaus MM, Hazen KC, Dicks KV, Lipuma JJ, Chen LF, Sexton DJ.

JAMA Intern Med. 2014 Apr;174(4):606-12. doi: 10.1001/jamainternmed.2013.13768.

PMID:
24493147
15.

Meningitis outbreak shines light on compounding pharmacies.

Shaughnessy AF.

BMJ. 2012 Nov 5;345:e7432. doi: 10.1136/bmj.e7432. No abstract available.

PMID:
23129491
16.

Meningitis mess. The trouble with custom-made drugs.

Park A.

Time. 2012 Oct 29;180(18):18. No abstract available.

PMID:
23156104
17.

Multistate fungal meningitis outbreak -- interim guidance for treatment.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2012 Oct 19;61(41):842.

18.

Fungal meningitis from injection of contaminated steroids: a compounding problem.

Wilson LE, Blythe D, Sharfstein JM.

JAMA. 2012 Dec 19;308(23):2461-2. doi: 10.1001/jama.2012.47932. No abstract available.

PMID:
23104261
19.

U.S. Compounding Pharmacy-Related Outbreaks, 2001-2013: Public Health and Patient Safety Lessons Learned.

Shehab N, Brown MN, Kallen AJ, Perz JF.

J Patient Saf. 2015 May 21. [Epub ahead of print]

20.

Outbreak of Serratia marcescens bloodstream infections in patients receiving parenteral nutrition prepared by a compounding pharmacy.

Gupta N, Hocevar SN, Moulton-Meissner HA, Stevens KM, McIntyre MG, Jensen B, Kuhar DT, Noble-Wang JA, Schnatz RG, Becker SC, Kastango ES, Shehab N, Kallen AJ.

Clin Infect Dis. 2014 Jul 1;59(1):1-8. doi: 10.1093/cid/ciu218.

Items per page

Supplemental Content

Support Center